DRTS - Alpha Tau Medical Ltd
Alpha Tau Medical Ltd. , a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.
As of Jun 30, 2026: spot at $12.48, ATM IV 94.3%, max pain $10.00, net GEX $135.5K.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- Market Cap
- $982.7M
- Beta
- 1.20
- 52-Week Range
- 2.87-11.62
- CEO
- Uzi Sofer
- Employees
- 118
- IPO Date
- Mar 8, 2021
- Exchange
- NASDAQ
What DRTS Looks Like to Options Traders Today
IV rank of 16.0% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); positive net gamma exposure ($135.5K) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.031) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The DRTS overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked DRTS overview questions
- What is DRTS?
- DRTS is the ticker symbol for Alpha Tau Medical Ltd, a listed security. Alpha Tau Medical Ltd. , a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Listed on NASDAQ. DRTS is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the DRTS options snapshot look like today?
- As of Jun 30, 2026, the DRTS options snapshot shows spot at $12.48, ATM IV 94.3%, IV rank 16.0%, max pain $10.00, net GEX $135.5K, expected move 27.03%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are DRTS's key statistics?
- Alpha Tau Medical Ltd (DRTS) carries a market capitalization of $982.7M, beta of 1.20 relative to the broader market, 52-week range of 2.87-11.62. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does DRTS belong to?
- Alpha Tau Medical Ltd operates in the Healthcare sector, in the Medical - Equipment & Services industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare DRTS's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the DRTS data on this page?
- The options snapshot above is dated Jun 30, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).